Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells.
暂无分享,去创建一个
[1] W. Forrester,et al. Inhibition of an Erythroid Differentiation Switch by the Helix-Loop-Helix Protein Id1 (*) , 1995, The Journal of Biological Chemistry.
[2] N. Takai,et al. Id1 expression is associated with histological grade and invasive behavior in endometrial carcinoma. , 2001, Cancer letters.
[3] T. Balla. Pharmacology of phosphoinositides, regulators of multiple cellular functions. , 2001, Current pharmaceutical design.
[4] L. Yamasaki. Balancing proliferation and apoptosis in vivo: the Goldilocks theory of E2F/DP action. , 1999, Biochimica et biophysica acta.
[5] A. Kasza,et al. Long-term culture of HepG2 hepatoma cells as a model for liver acute phase response during chronic inflammation. Effects of interleukin-6, dexamethasone and retinoic acid. , 1994, Biological chemistry Hoppe-Seyler.
[6] V. Misra,et al. Different cellular localization, translocation, and insulin‐induced phosphorylation of PKBα in HepG2 cells and hepatocytes , 2002, Journal of cellular biochemistry.
[7] H. Yamazaki,et al. Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. , 1994, The Journal of pharmacology and experimental therapeutics.
[8] P. Schirmacher,et al. Reactivation of insulin-like growth factor II during hepatocarcinogenesis in transgenic mice suggests a role in malignant growth. , 1992, Cancer research.
[9] C. Bréchot,et al. Insulin-like growth factor II (IGF-II) mRNA expression during hepatocarcinogenesis in transgenic mice. , 1991, Journal of hepatology.
[10] J. Essigmann,et al. Metabolic activation of aflatoxin B1: patterns of DNA adduct formation, removal, and excretion in relation to carcinogenesis. , 1982, Drug metabolism reviews.
[11] I. Screpanti,et al. Differential regulation of E2F1 apoptotic target genes in response to DNA damage , 2003, Nature Cell Biology.
[12] H. Kleinman,et al. Regulation of gene expression in adult rat hepatocytes cultured on a basement membrane matrix , 1988, Journal of cellular physiology.
[13] J. Gauldie,et al. Interaction among hepatocyte-stimulating factors, interleukin 1, and glucocorticoids for regulation of acute phase plasma proteins in human hepatoma (HepG2) cells. , 1987, Journal of immunology.
[14] M. A. Hayes,et al. Comparative cytopathology of primary rat hepatocyte cultures exposed to aflatoxin B1, acetaminophen, and other hepatotoxins. , 1985, Toxicology and applied pharmacology.
[15] C. Bréchot,et al. Expression of insulin-like growth factor II (IGF-II) in human primary liver cancer: mRNA and protein analysis. , 1990, Journal of hepatology.
[16] K. Kunii,et al. Type II Phosphatidylinositol 4-Kinase β Is a Cytosolic and Peripheral Membrane Protein That Is Recruited to the Plasma Membrane and Activated by Rac-GTP* , 2002, The Journal of Biological Chemistry.
[17] K. Yamada,et al. Diacylglycerol kinase: a key modulator of signal transduction? , 1990, Trends in biochemical sciences.
[18] B E Butterworth,et al. Use of primary cultures of human hepatocytes in toxicology studies. , 1989, Cancer research.
[19] M. Bissell,et al. Suppression of mammary epithelial cell differentiation by the helix-loop-helix protein Id-1 , 1995, Molecular and cellular biology.
[20] N. Javitt. Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] Keiko Yamada,et al. Alternative Splicing of the Human Diacylglycerol Kinase δ Gene Generates Two Isoforms Differing in Their Expression Patterns and in Regulatory Functions* , 2002, The Journal of Biological Chemistry.
[22] J. Enghild,et al. Biosynthesis of Bikunin Proteins in the Human Carcinoma Cell Line HepG2 and in Primary Human Hepatocytes , 1995, The Journal of Biological Chemistry.
[23] William S. Ball,et al. X-linked creatine-transporter gene (SLC6A8) defect: a new creatine-deficiency syndrome. , 2001, American journal of human genetics.
[24] P. De Camilli,et al. Phosphatidylinositol 4-kinase type IIalpha is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] L. Richert,et al. Peroxisome proliferators induce apoptosis and decrease DNA synthesis in hepatoma cell lines , 2000, Human & experimental toxicology.
[26] Kun Wang,et al. Advantages of in vitro cytotoxicity testing by using primary rat hepatocytes in comparison with established cell lines. , 2002, The Journal of toxicological sciences.
[27] Thierry Lavé,et al. Influence of isolation procedure, extracellular matrix and dexamethasone on the regulation of membrane transporters gene expression in rat hepatocytes. , 2002, Biochemical pharmacology.
[28] R. Wanders,et al. Peroxisomal enzyme activities in the human hepatoblastoma cell line HepG2 as compared to human liver. , 1991, Biochimica et biophysica acta.
[29] W. Pan,et al. Analysis by cDNA microarrays of altered gene expression in middle ears of rats following pneumococcal infection. , 2002, International journal of pediatric otorhinolaryngology.
[30] S. Sarraj,et al. Reconstitution of dna synthetic capacity in senescent normal human fibroblasts by expressing cellular factors E2F and Mdm2. , 2001, Experimental cell research.
[31] R G Ulrich,et al. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. , 2001, Toxicology letters.
[32] G. Everson,et al. Bile acid synthesis in cultured human hepatoblastoma cells. , 1991, The Journal of biological chemistry.
[33] J. Castell,et al. Re‐expression of C/EBPα induces CYP2B6, CYP2C9 and CYP2D6 genes in HepG2 cells , 1998 .
[34] S. Thorgeirsson,et al. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis , 2000, Oncogene.
[35] T. Südhof,et al. A Novel Family of Phosphatidylinositol 4-Kinases Conserved from Yeast to Humans* , 2001, The Journal of Biological Chemistry.
[36] A. Klein-Szanto,et al. E2F-1 gene transfer enhances invasiveness of human head and neck carcinoma cell lines. , 2000, Cancer research.
[37] J. Campisi,et al. Id-related genes encoding helix-loop-helix proteins are required for G1 progression and are repressed in senescent human fibroblasts. , 1994, The Journal of biological chemistry.
[38] D. Schrenk,et al. Induction of CYP1A and glutathione S-transferase activities by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatocyte cultures. , 1995, Carcinogenesis.
[39] D. Ginsberg,et al. ATM is a target for positive regulation by E2F-1 , 2003, Oncogene.
[40] O. Sugita,et al. Drug metabolism by the human hepatoma cell, Hep G2. , 1987, Biochemical and biophysical research communications.
[41] D. Tuma,et al. Establishment of a recombinant hepatic cell line stably expressing alcohol dehydrogenase. , 1995, Archives of biochemistry and biophysics.
[42] T. K. Baker,et al. Temporal gene expression analysis of monolayer cultured rat hepatocytes. , 2001, Chemical research in toxicology.
[43] Silvio Albertini,et al. Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. , 2003, Toxicological sciences : an official journal of the Society of Toxicology.
[44] N. Plant,et al. Receptor-dependent transcriptional activation of cytochrome P4503A genes: induction mechanisms, species differences and interindividual variation in man , 2002, Xenobiotica; the fate of foreign compounds in biological systems.
[45] Masakazu Ueda,et al. TFDP1, CUL4A, and CDC16 identified as targets for amplification at 13q34 in hepatocellular carcinomas , 2002, Hepatology.
[46] M. P. Carrasco,et al. Evidence of differential effects produced by ethanol on specific phospholipid biosynthetic pathways in rat hepatocytes , 1996, British journal of pharmacology.
[47] R. W. Niessen,et al. The Influence of Insulin, ß-Estradiol, Dexamethasone and Thyroid Hormone on the Secretion of Coagulant and Anticoagulant Proteins by HepG2 Cells , 1995, Thrombosis and Haemostasis.
[48] R. Fisher,et al. Expression and inducibility of the human bilirubin UDP‐glucuronosyltransferase UGT1A1 in liver and cultured primary hepatocytes: Evidence for both genetic and environmental influences , 1999, Hepatology.
[49] R. Stevenson,et al. X-linked mental retardation with seizures and carrier manifestations is caused by a mutation in the creatine-transporter gene (SLC6A8) located in Xq28. , 2002, American journal of human genetics.
[50] I. White,et al. Major inter-species differences in the rates of O-sulphonation and O-glucuronylation of alpha-hydroxytamoxifen in vitro: a metabolic disparity protecting human liver from the formation of tamoxifen-DNA adducts. , 2000, Carcinogenesis.
[51] D. Barlow,et al. Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27. , 1999, Genomics.
[52] W. Hong,et al. Overexpression of E2F‐1 in rat embryo fibroblasts leads to neoplastic transformation. , 1994, The EMBO journal.
[53] C. Wolf,et al. Induction of drug metabolizing enzymes in human liver cell line Hep G2 , 1985, FEBS letters.
[54] Incorporation of exogenous precursors into neutral lipids and phospholipids in rat hepatocytes: effect of ethanol in vitro. , 1998, Biochemical pharmacology.
[55] Jie Liu,et al. Stress-related gene expression in mice treated with inorganic arsenicals. , 2001, Toxicological sciences : an official journal of the Society of Toxicology.
[56] K. Polonsky,et al. Tumor hypoglycemia: relationship to high molecular weight insulin-like growth factor-II. , 1990, The Journal of clinical investigation.
[57] C C Howe,et al. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. , 1980, Science.
[58] M. Grant,et al. Mixed function oxidase and UDP-glucuronyltransferase activities in the human Hep G2 hepatoma cell line. , 1988, Biochemical pharmacology.
[59] R. Edwards,et al. Cytochrome P450 expression in human hepatocytes and hepatoma cell lines: molecular mechanisms that determine lower expression in cultured cells , 2002, Xenobiotica; the fate of foreign compounds in biological systems.
[60] D. Ginsberg,et al. E2F Mediates Sustained G2 Arrest and Down-regulation of Stathmin and AIM-1 Expression in Response to Genotoxic Stress* , 2003, The Journal of Biological Chemistry.
[61] R. Heller,et al. Global expression profiling of fibroblast responses to transforming growth factor-beta1 reveals the induction of inhibitor of differentiation-1 and provides evidence of smooth muscle cell phenotypic switching. , 2003, The American journal of pathology.
[62] N. L. La Thangue,et al. A new component of the transcription factor DRTF1/E2F , 1993, Nature.
[63] Heinz Bönisch,et al. Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3 , 2002, British journal of pharmacology.
[64] M. Honda,et al. α‐fetoprotein‐producing hepatoma cell lines share common expression profiles of genes in various categories demonstrated by cDNA microarray analysis , 2001 .
[65] K. Iyer,et al. Characterization of Phase I and Phase II hepatic drug metabolism activities in a panel of human liver preparations. , 1999, Chemico-biological interactions.
[66] M. P. Carrasco,et al. Resistance of HepG2 cells against the adverse effects of ethanol related to neutral lipid and phospholipid metabolism. , 2002, Biochemical pharmacology.
[67] J. Brady,et al. Expression profiling of acetaminophen liver toxicity in mice using microarray technology. , 2001, Biochemical and biophysical research communications.
[68] S. Langouet,et al. Preferential increase of glutathione S-transferase class alpha transcripts in cultured human hepatocytes by phenobarbital, 3-methylcholanthrene, and dithiolethiones. , 1993, Cancer research.
[69] Harold Weintraub,et al. The protein Id: A negative regulator of helix-loop-helix DNA binding proteins , 1990, Cell.
[70] J. Hsuan,et al. Cloning of a Human Type II Phosphatidylinositol 4-Kinase Reveals a Novel Lipid Kinase Family* , 2001, The Journal of Biological Chemistry.
[71] S. R. Nash,et al. Cloning, pharmacological characterization, and genomic localization of the human creatine transporter. , 1994, Receptors & channels.
[72] J. Pevsner,et al. Microarray analysis of differential gene expression in lead-exposed astrocytes. , 2001, Toxicology and applied pharmacology.